1 February 2023 v2024.53.1 limited_company_frs_102_section_1a_v1_1_2 companies_houseSoftwarefalsetruetruetrueNo description of principal activity00falsetruexbrli:purexbrli:sharesiso4217:GBP053249002023-02-012024-01-31053249002024-01-31053249002023-01-3105324900core:WithinOneYear2024-01-3105324900core:WithinOneYear2023-01-3105324900core:ShareCapital2024-01-3105324900core:ShareCapital2023-01-3105324900core:RetainedEarningsAccumulatedLosses2024-01-3105324900core:RetainedEarningsAccumulatedLosses2023-01-3105324900bus:Director12023-02-012024-01-3105324900bus:RegisteredOffice2023-02-012024-01-3105324900core:PlantMachinery2024-01-3105324900core:PlantMachinery2023-02-0105324900core:PlantMachinery2023-02-012024-01-3105324900core:PlantMachinery2023-01-310532490012023-02-012024-01-31053249002022-02-012023-01-3105324900countries:EnglandWales2023-02-012024-01-3105324900bus:AuditExemptWithAccountantsReport2023-02-012024-01-3105324900bus:PrivateLimitedCompanyLtd2023-02-012024-01-3105324900bus:SmallEntities2023-02-012024-01-3105324900bus:FullAccounts2023-02-012024-01-31
Company registration number:
05324900
Bio Pharma Resourcing Ltd
Unaudited Filleted Financial Statements for the year ended
31 January 2024
Bio Pharma Resourcing Ltd
Statement of Financial Position
31 January 2024
20242023
Note££
Fixed assets    
Tangible assets 4
63
 
79
 
Current assets    
Cash at bank and in hand
45,338
 
30,727
 
Creditors: amounts falling due within one year 5
(5,422
)
(1,812
)
Net current assets
39,916
 
28,915
 
Total assets less current liabilities 39,979   28,994  
Capital and reserves    
Called up share capital
100
 
100
 
Profit and loss account
39,879
 
28,894
 
Shareholders funds
39,979
 
28,994
 
For the year ending
31 January 2024
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
1 October 2024
, and are signed on behalf of the board by:
Patricia Tuckwell
Director
Company registration number:
05324900
Bio Pharma Resourcing Ltd
Notes to the Financial Statements
Year ended
31 January 2024

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
Falstaff House
,
36 Bardolph Road
,
Richmond
,
Surrey
,
TW9 2LH
, United Kingdom.

2 Accounting policies

3 Average number of employees

The average number of persons employed by the company during the year was Nil (2023: Nil).

4 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 February 2023
and
31 January 2024
1,962
 
Depreciation  
At
1 February 2023
1,883
 
Charge
16
 
At
31 January 2024
1,899
 
Carrying amount  
At
31 January 2024
63
 
At 31 January 2023
79
 

5 Creditors: amounts falling due within one year

20242023
££
Taxation and social security
2,580
 
417
 
Other creditors
2,842
 
1,395
 
5,422
 
1,812